These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 15250025)

  • 1. Antimicrobial prophylaxis in febrile neutropenia.
    Yoshida M; Ohno R
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S65-7. PubMed ID: 15250025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial prophylaxis with trimethoprim-sulfamethoxazole during induction treatment for acute lymphoblastic leukemia.
    Schrøder H; Agger KE; Rosthøj S; Carlsen NT; Schmiegelow K
    Dan Med Bull; 2001 Nov; 48(4):275-7. PubMed ID: 11767129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based recommendations for antimicrobial use in febrile neutropenia in Japan: executive summary.
    Masaoka T
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S49-52. PubMed ID: 15250021
    [No Abstract]   [Full Text] [Related]  

  • 4. [Trimethoprim-sulfamethoxazole as antibacterial prophylaxis during induction therapy of children with acute lymphatic leukemia].
    Agger KE; Schrøder H; Rosthøj S; Carlsen NT; Schmiegelow K
    Ugeskr Laeger; 2002 Jan; 164(4):488-92. PubMed ID: 11838420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current antimicrobial usage for the management of infections in leukemic patients in Japan: results of a survey.
    Yoshida M; Ohno R
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S11-4. PubMed ID: 15250015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens.
    Ramphal R
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S25-31. PubMed ID: 15250017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between antifungal prophylaxis and rate of documented bacteremia in febrile neutropenic cancer patients.
    Viscoli C; Paesmans M; Sanz M; Castagnola E; Klastersky J; Martino P; Glauser M;
    Clin Infect Dis; 2001 Jun; 32(11):1532-7. PubMed ID: 11340522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empirical antifungal therapy in treating febrile neutropenic patients.
    Wingard JR
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S38-43. PubMed ID: 15250019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Infectious Diseases Society of America 2002 guidelines for the use of antimicrobial agents in patients with cancer and neutropenia: salient features and comments.
    Rolston KV
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S44-8. PubMed ID: 15250020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
    Oren I; Rowe JM; Sprecher H; Tamir A; Benyamini N; Akria L; Gorelik A; Dally N; Zuckerman T; Haddad N; Fineman R; Dann EJ
    Bone Marrow Transplant; 2006 Jul; 38(2):127-34. PubMed ID: 16751782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli.
    Gomez L; Garau J; Estrada C; Marquez M; Dalmau D; Xercavins M; Martí JM; Estany C
    Cancer; 2003 Jan; 97(2):419-24. PubMed ID: 12518366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of patients with hematologic neoplasm, fever, and neutropenia.
    Sepkowitz KA
    Clin Infect Dis; 2005 Apr; 40 Suppl 4():S253-6. PubMed ID: 15768331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
    Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
    Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of the febrile neutropenic patient: a consensus conference.
    Picazo JJ
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S1-6. PubMed ID: 15250013
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of fever in neutropenic patients with different risks of complications.
    Klastersky J
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S32-7. PubMed ID: 15250018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiological data for patients with febrile neutropenia.
    Kanamaru A; Tatsumi Y
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S7-S10. PubMed ID: 15250014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antimicrobial prophylaxis and therapy in neutropenia].
    Link H
    Mycoses; 2003; 46 Suppl 2():21-32. PubMed ID: 15055140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteremia and fungemia in pediatric versus adult cancer patients after chemotherapy: comparison of etiology, risk factors and outcome.
    Krupova I; Kaiserova E; Foltinova A; Kovacicova G; Kiskova M; Krchnakova A; Kunova A; Trupl J; West D; Krcmery V
    J Chemother; 1998 Jun; 10(3):236-42. PubMed ID: 9669650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of systemic mycoses in patients who are not neutropenic: should we do it? Can we do it?
    Graybill JR
    Braz J Infect Dis; 2000 Jun; 4(3):108-12. PubMed ID: 10934492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions.
    Leibovici L; Paul M; Cullen M; Bucaneve G; Gafter-Gvili A; Fraser A; Kern WV
    Cancer; 2006 Oct; 107(8):1743-51. PubMed ID: 16977651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.